This Chemours Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Avi Kapoor 1 month ago
MarketsTrading IdeasPre-Market OutlookNewsAnalyst RatingsDowngrades
Analysts downgraded CTNM, CC, ACI, BRKR and SAFE; targets fell for CTNM, CC and ACI, while BRKR received a new $60 target.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Baird analyst Joel Beatty downgraded Contineum Therapeutics Inc (NASDAQ:CTNM) from Outperform to Neutral and cut the price target from $19 to $14. Contineum Therapeutics closed at $8.42 on Tuesday. See how other analysts view this stock.
- Mizuho analyst John Roberts downgraded Chemours Co (NYSE:CC) from Outperform to Neutral and lowered the price target from $18 to $15. Chemours shares closed at $13.20 on Tuesday. See how other analysts view this stock.
- B of A Securities analyst Kendall Toscano downgraded Albertsons Companies Inc (NYSE:ACI) from Neutral to Underperform and slashed the price target from $16 to $12. Albertsons closed at $12.72 on Tuesday. See how other analysts view this stock.
- JP Morgan analyst Casey Woodring downgraded Bruker Corp (NASDAQ:BRKR) from Overweight to Neutral and announced a $60 price target. Bruker shares closed at $56.19 on Tuesday. See how other analysts view this stock.
- Citizens analyst Mitch Germain downgraded Safehold Inc. (NYSE:SAFE) from Market Outperform to Market Perform. Safehold closed at $11.97 on Tuesday. See how other analysts view this stock.
Considering buying CC stock? Here’s what analysts think:
Photo via Shutterstock